Valsartan and Hydrochlorothiazide

Product NDC
46708-455
11-digit product format
467080455
Labeler code
46708
Product ID
46708-455_7fb28413-d2ab-4534-8f12-48ce33bbc6a9
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Valsartan and Hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Alembic Pharmaceuticals Limited
Application
ANDA201662
Marketing category
ANDA
Marketing start
2016-05-20
Substance
HYDROCHLOROTHIAZIDE; VALSARTAN
Active strength
25; 160 mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Valsartan and Hydrochlorothiazide
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
HYDROCHLOROTHIAZIDE25 mg/1
VALSARTAN160 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii80M03YXJ7I, 0J48LPH2TH
Rxcui200284, 200285, 349353, 636042, 636045

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
692a3434-fece-49c6-9b7d-ed7aefc52b50Product name320260317
c19ec24d-2c40-4b8d-7c20-500ffa3660a1Product name320260303
1199f4b7-b537-466c-9a1c-cb09131e9f8bProduct name120251117
e1a63b6e-1877-c2c1-01a3-03ea2817aa6fProduct name320251027
b15e9aa6-d523-ca97-480e-570e0543a342Product name420251024
265792b3-b999-c010-7364-a7db20b9d4d9Product name520250515
96816964-c075-ffa7-b7b8-d8570411a3b9Product name720250305
e7dfdaab-7cf9-4f89-804c-eff5108d94d1Product name920250305
b6abae2f-ee27-47bc-b150-54dc8d969483Product name220250221
52311e76-a520-4bd2-9d5b-e0b6d6f44519Product name220231208
162cbc9d-ecc3-72ba-af9f-c76e2756ef54Product name320221207
9b303cd4-3186-2454-5706-3137e8b2dfd2Product name420221110
47fc2fe9-7afb-4be9-989d-787aaa6ad0eaProduct name120200505
a8e65197-7914-7acf-c7ec-914d53819b34Product name320190624
8b67f333-47d1-8464-7ce4-406d3dbb295fProduct name720190618
89a57420-ab44-5323-14f9-595159145f9bProduct name220190612
c27b049d-3258-48cf-ebe5-08c236ae78e2Product name320190610
00fc2cf9-672f-3e0b-6afa-43cbc864d058Product name420180613
15b375b1-89c7-9594-80df-5a8c8864aee0Product name320180108
a7349398-661d-d9fc-46df-7e128bbd61d9Product name520171113
1bdb87cf-9b1f-6a51-5eb7-d182aaffaa3dProduct name220170719
e0eeb018-194e-4b70-a57d-bac47a97b8eaProduct name120160825
55bffd21-17e1-ff02-2e8f-1f9a532b9502Product name220150320
ea069444-e874-4c28-833f-d2f52734ef4dProduct name120150206
041df61b-f8b6-48a6-7b67-411e1412678bProduct name120140508
0ad8bdca-888e-00da-648b-6a4de854a167Product name120140508
433a3439-b8f3-d13a-d2c8-9b221d628d60Product name120140508
59212689-39e5-a976-6d21-882d76d8079aProduct name120140508
7613b1a5-acb6-4e5e-6048-c44deeeb1212Product name120140508
78637fb0-95c8-441f-e4b4-db1274b6f956Product name120140508
df89bd47-2db4-d593-ab37-d11953fd5536Product name120140508
f151007d-265d-9fbe-857d-1d44f1cb76baProduct name120140508
f5231d08-c52b-a5a0-ba93-675895c292beProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
46708-455-102023-02-01C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-302023-02-01C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-712023-02-01C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-902023-02-01C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-102023-01-30C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-302023-01-30C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-712023-01-30C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998
46708-455-902023-01-30C16284748780-1f386c649-ddce-0266-e053-dadaa90a7c1aThese highlights do not include all the information needed to use valsartan and hydrochlorothiazide tablets safely and effectively. See full prescribing information for valsartan and hydrochlorothiazide tablets. VALSARTAN and HYDROCHLOROTHIAZIDE Tablets, USP for oral use. Initial U.S. Approval: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
46708-455-10Valsartan and Hydrochlorothiazide100 in 1 BOTTLETABLET, FILM COATED1003
46708-455-30Valsartan and Hydrochlorothiazide30 in 1 BOTTLETABLET, FILM COATED303
46708-455-71Valsartan and Hydrochlorothiazide500 in 1 BOTTLETABLET, FILM COATED5003
46708-455-90Valsartan and Hydrochlorothiazide90 in 1 BOTTLETABLET, FILM COATED903

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
46708-455VALSARTAN AND HYDROCHLOROTHIAZIDE TABLET, FILM COATED [ALEMBIC PHARMACEUTICALS LIMITED]3Current NDC, Legacy NDC, 4 package rows20230202_3b80f726-9e1e-4d44-ad4f-afd10e26292f.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
200284HCTZ 12.5 MG / valsartan 80 MG Oral TabletPSN3b80f726-9e1e-4d44-ad4f-afd10e26292f3
200285valsartan 160 MG / hydroCHLOROthiazide 12.5 MG Oral TabletPSN3b80f726-9e1e-4d44-ad4f-afd10e26292f3
349353valsartan 160 MG / hydroCHLOROthiazide 25 MG Oral TabletPSN3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636042valsartan 320 MG / hydroCHLOROthiazide 12.5 MG Oral TabletPSN3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636045valsartan 320 MG / hydroCHLOROthiazide 25 MG Oral TabletPSN3b80f726-9e1e-4d44-ad4f-afd10e26292f3
200285hydrochlorothiazide 12.5 MG / valsartan 160 MG Oral TabletSCD3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636042hydrochlorothiazide 12.5 MG / valsartan 320 MG Oral TabletSCD3b80f726-9e1e-4d44-ad4f-afd10e26292f3
200284hydrochlorothiazide 12.5 MG / valsartan 80 MG Oral TabletSCD3b80f726-9e1e-4d44-ad4f-afd10e26292f3
349353hydrochlorothiazide 25 MG / valsartan 160 MG Oral TabletSCD3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636045hydrochlorothiazide 25 MG / valsartan 320 MG Oral TabletSCD3b80f726-9e1e-4d44-ad4f-afd10e26292f3
200285HCTZ 12.5 MG / valsartan 160 MG Oral TabletSY3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636042HCTZ 12.5 MG / valsartan 320 MG Oral TabletSY3b80f726-9e1e-4d44-ad4f-afd10e26292f3
200284HCTZ 12.5 MG / valsartan 80 MG Oral TabletSY3b80f726-9e1e-4d44-ad4f-afd10e26292f3
349353HCTZ 25 MG / valsartan 160 MG Oral TabletSY3b80f726-9e1e-4d44-ad4f-afd10e26292f3
636045HCTZ 25 MG / valsartan 320 MG Oral TabletSY3b80f726-9e1e-4d44-ad4f-afd10e26292f3

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
46708-455-1046708045510100 TABLET, FILM COATED in 1 BOTTLE (46708-455-10) 2016-05-200000-00-00NoNoCurrent
46708-455-304670804553030 TABLET, FILM COATED in 1 BOTTLE (46708-455-30) 2016-05-200000-00-00NoNoCurrent
46708-455-7146708045571500 TABLET, FILM COATED in 1 BOTTLE (46708-455-71) 2016-05-200000-00-00NoNoCurrent
46708-455-904670804559090 TABLET, FILM COATED in 1 BOTTLE (46708-455-90) 2016-05-200000-00-00NoNoCurrent